Erik D. Brady

1.4k total citations
21 papers, 1.1k citations indexed

About

Erik D. Brady is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry. According to data from OpenAlex, Erik D. Brady has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Erik D. Brady's work include Radiopharmaceutical Chemistry and Applications (11 papers), Organometallic Complex Synthesis and Catalysis (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Erik D. Brady is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Organometallic Complex Synthesis and Catalysis (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Erik D. Brady collaborates with scholars based in United States. Erik D. Brady's co-authors include Martin W. Brechbiel, Diane E. Milenic, Kayhan Garmestani, Paul S. Albert, Timothy P. Hanusa, Hyun‐Soon Chong, Victor G. Young, Dangshe Ma, Maren Pink and John G. Watkin and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Nature Reviews Drug Discovery.

In The Last Decade

Erik D. Brady

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik D. Brady United States 18 621 271 246 187 183 21 1.1k
Jean‐François Gestin France 21 905 1.5× 185 0.7× 336 1.4× 135 0.7× 248 1.4× 64 1.3k
Martin Walther Germany 19 542 0.9× 169 0.6× 222 0.9× 112 0.6× 183 1.0× 66 946
P. August Schubiger Switzerland 13 837 1.3× 350 1.3× 451 1.8× 227 1.2× 199 1.1× 19 1.1k
Lihui Wei United States 16 757 1.2× 155 0.6× 365 1.5× 103 0.6× 157 0.9× 37 1.2k
Paul Jurek United States 14 767 1.2× 154 0.6× 480 2.0× 126 0.7× 245 1.3× 25 1.2k
Kim A. Deal United States 12 423 0.7× 207 0.8× 385 1.6× 165 0.9× 130 0.7× 14 871
James C. Knight United Kingdom 18 288 0.5× 437 1.6× 314 1.3× 133 0.7× 83 0.5× 57 1.1k
Paul D. Benny United States 20 562 0.9× 214 0.8× 328 1.3× 119 0.6× 190 1.0× 40 850
F.J. Femia United States 20 860 1.4× 282 1.0× 511 2.1× 214 1.1× 425 2.3× 35 1.4k
M. Isabel M. Prata Portugal 17 558 0.9× 90 0.3× 200 0.8× 103 0.6× 125 0.7× 31 870

Countries citing papers authored by Erik D. Brady

Since Specialization
Citations

This map shows the geographic impact of Erik D. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik D. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik D. Brady more than expected).

Fields of papers citing papers by Erik D. Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik D. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik D. Brady. The network helps show where Erik D. Brady may publish in the future.

Co-authorship network of co-authors of Erik D. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Erik D. Brady. A scholar is included among the top collaborators of Erik D. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik D. Brady. Erik D. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quill, Timothy A., Shaji Kumar, Suzanne Lentzsch, et al.. (2015). Changes in Expert Recommendations and Global Practice Patterns from 2012-2015: Results from an Annually Updated Online Decision Aid for Multiple Myeloma (MM). Blood. 126(23). 2105–2105. 1 indexed citations
2.
Milenic, Diane E., et al.. (2010). Improved efficacy of α‐particle–targeted radiation therapy. Cancer. 116(S4). 1059–1066. 45 indexed citations
3.
Brady, Erik D., Timothy P. Hanusa, G.T. Yee, et al.. (2008). Tunable Spin-Crossover Behavior in Polymethylated Bis(indenyl)chromium(II) Complexes: The Significance of Benzo-Ring Substitution. Organometallics. 27(21). 5464–5473. 20 indexed citations
4.
Brady, Erik D., Stephen C. Chmely, Kumudini C. Jayaratne, Timothy P. Hanusa, & Victor G. Young. (2008). s-Block Metal Complexes of the Bis(tetramethylcyclopentadienyl) Phosphonium Diylide [Me(t-Bu)P(C5Me4)2]−. Organometallics. 27(7). 1612–1616. 17 indexed citations
5.
Chong, Hyun‐Soon, Hyun A. Song, Xiang Ma, et al.. (2008). Novel Bimodal Bifunctional Ligands for Radioimmunotherapy and Targeted MRI. Bioconjugate Chemistry. 19(7). 1439–1447. 38 indexed citations
6.
Milenic, Diane E., Kayhan Garmestani, Erik D. Brady, et al.. (2007). Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease. Clinical Cancer Research. 13(6). 1926–1935. 61 indexed citations
7.
Chong, Hyun‐Soon, Xiang Ma, Diane E. Milenic, et al.. (2007). Rational Design and Generation of a Bimodal Bifunctional Ligand for Antibody-Targeted Radiation Cancer Therapy. Journal of Medicinal Chemistry. 51(1). 118–125. 30 indexed citations
8.
Chong, Hyun‐Soon, Diane E. Milenic, Kayhan Garmestani, et al.. (2006). In vitro and in vivo evaluation of novel ligands for radioimmunotherapy. Nuclear Medicine and Biology. 33(4). 459–467. 34 indexed citations
9.
Brady, Erik D., Timothy P. Hanusa, G.T. Yee, et al.. (2006). High-Spin and Spin-Crossover Behavior in Monomethylated Bis(indenyl)chromium(II) Complexes. Organometallics. 25(21). 4945–4952. 18 indexed citations
10.
Chong, Hyun‐Soon, Kayhan Garmestani, L. Henry Bryant, et al.. (2006). Synthesis and Evaluation of Novel Macrocyclic and Acyclic Ligands as Contrast Enhancement Agents for Magnetic Resonance Imaging. Journal of Medicinal Chemistry. 49(6). 2055–2062. 26 indexed citations
11.
Garmestani, Kayhan, Diane E. Milenic, Erik D. Brady, Paul S. Plascjak, & Martin W. Brechbiel. (2005). Purification of cyclotron-produced 203Pb for labeling Herceptin. Nuclear Medicine and Biology. 32(3). 301–305. 19 indexed citations
12.
Milenic, Diane E., Kayhan Garmestani, Erik D. Brady, et al.. (2005). α-Particle Radioimmunotherapy of Disseminated Peritoneal Disease Using a 212 Pb-Labeled Radioimmunoconjugate Targeting HER2. Cancer Biotherapy and Radiopharmaceuticals. 20(5). 557–568. 86 indexed citations
13.
Milenic, Diane E., Erik D. Brady, & Martin W. Brechbiel. (2004). Antibody-targeted radiation cancer therapy. Nature Reviews Drug Discovery. 3(6). 488–499. 289 indexed citations
14.
Brady, Erik D., Hyun‐Soon Chong, Diane E. Milenic, & Martin W. Brechbiel. (2004). Development of a spectroscopic assay for bifunctional ligand-protein conjugates based on copper. Nuclear Medicine and Biology. 31(6). 795–802. 43 indexed citations
15.
Brady, Erik D., Diane E. Milenic, & Martin W. Brechbiel. (2004). Antibody guided precision radiation therapy.. PubMed. 4(22). 213–9. 2 indexed citations
16.
Milenic, Diane E., Kayhan Garmestani, Erik D. Brady, et al.. (2004). Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease. Clinical Cancer Research. 10(23). 7834–7841. 67 indexed citations
17.
Brady, Erik D., David L. Clark, John C. Gordon, et al.. (2003). Tris(bis(trimethylsilyl)amido)samarium:  X-ray Structure and DFT Study. Inorganic Chemistry. 42(21). 6682–6690. 86 indexed citations
18.
Brady, Erik D., et al.. (2002). Spin-State Alteration from Sterically Enforced Ligand Rotation in Bis(indenyl)chromium(II) Complexes1. Journal of the American Chemical Society. 124(32). 9556–9566. 28 indexed citations
19.
Brady, Erik D., David L. Clark, D. Webster Keogh, Brian L. Scott, & John G. Watkin. (2002). A Mechanistic Study of the Samarium(II)-Mediated Reduction of Aryl Nitro Compounds to the Corresponding Arylamines. The Crystal Structures of {Sm[N(SiMe3)2]2(thf)}2(μ2-O) and [(Me3Si)2N]2Sm(thf)(μ-PhNNPh)Sm[N(SiMe3)2]2. Journal of the American Chemical Society. 124(24). 7007–7015. 46 indexed citations
20.
Brady, Erik D., Timothy P. Hanusa, Maren Pink, & Victor G. Young. (2000). The First Noncoordinated Phosphonium Diylide, [Me2P(C13H8)2]-, and Its Ylidic and Cationic Counterparts:  Synthesis, Structural Characterization, and Interaction with the Heavy Group 2 Metals. Inorganic Chemistry. 39(26). 6028–6037. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐François Gestin Breakdown of academic impact, for papers by Martin Walther Breakdown of academic impact, for papers by P. August Schubiger Breakdown of academic impact, for papers by Lihui Wei Breakdown of academic impact, for papers by Paul Jurek Breakdown of academic impact, for papers by Kim A. Deal Breakdown of academic impact, for papers by James C. Knight Breakdown of academic impact, for papers by Paul D. Benny Breakdown of academic impact, for papers by F.J. Femia Breakdown of academic impact, for papers by M. Isabel M. Prata
Rankless by CCL
2026